← Back to Search

Coiling Device

Target 360°, 2D, Nano Coils for Intracranial Aneurysms (TARGET Trial)

N/A
Waitlist Available
Led By Osama O Zaidat, MD, MS
Research Sponsored by Mercy Health Ohio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-9 month follow-up
Awards & highlights

Summary

The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.

Eligible Conditions
  • Intracranial Aneurysms

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-9 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-9 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Packing Density
Secondary outcome measures
Aneurysm Bleed and Re-bleed Rate
Aneurysm Re-access Rate
Aneurysm Re-treatment Rate
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Target 360°, 2D, Nano CoilsExperimental Treatment1 Intervention
Subjects will undergo embolization using Target 360°, 2D, Nano Coils for the treatment of their intracranial aneurysm.

Find a Location

Who is running the clinical trial?

Mercy Health OhioLead Sponsor
14 Previous Clinical Trials
1,455 Total Patients Enrolled
Stryker NeurovascularIndustry Sponsor
35 Previous Clinical Trials
12,589 Total Patients Enrolled
5 Trials studying Intracranial Aneurysms
1,067 Patients Enrolled for Intracranial Aneurysms
Osama O Zaidat, MD, MSPrincipal InvestigatorMercy Health St. Vincent Medical Center
4 Previous Clinical Trials
1,204 Total Patients Enrolled
1 Trials studying Intracranial Aneurysms
~12 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top